

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.57188798 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 5.01366820 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 5.01366820 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.01366820 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.01366820 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.01366820 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.01366820 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.70673037 |
| 9 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.57544274 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.29448217 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.29448217 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.21262188 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.20147750 |
| 14 | neutrophil mediated immunity (GO:0002446) | 4.11549175 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.11244147 |
| 16 | response to muramyl dipeptide (GO:0032495) | 4.10939443 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.08132559 |
| 18 | cellular response to interferon-beta (GO:0035458) | 4.07038074 |
| 19 | response to peptidoglycan (GO:0032494) | 3.99718883 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 3.94825591 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.89173963 |
| 22 | respiratory burst (GO:0045730) | 3.88279066 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 3.77676782 |
| 24 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.74722051 |
| 25 | regulation of interferon-alpha production (GO:0032647) | 3.73468953 |
| 26 | positive regulation of antigen processing and presentation (GO:0002579) | 3.70370174 |
| 27 | negative regulation of phagocytosis (GO:0050765) | 3.65651121 |
| 28 | negative regulation of cell killing (GO:0031342) | 3.65111807 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.65111807 |
| 30 | neutrophil activation (GO:0042119) | 3.63936126 |
| 31 | positive regulation of B cell differentiation (GO:0045579) | 3.61029344 |
| 32 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.53294513 |
| 33 | macrophage activation involved in immune response (GO:0002281) | 3.52186557 |
| 34 | detection of bacterium (GO:0016045) | 3.50006947 |
| 35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.44619447 |
| 36 | response to host immune response (GO:0052572) | 3.44619447 |
| 37 | granulocyte activation (GO:0036230) | 3.43762158 |
| 38 | detection of molecule of bacterial origin (GO:0032490) | 3.41148213 |
| 39 | cellular extravasation (GO:0045123) | 3.37780207 |
| 40 | definitive hemopoiesis (GO:0060216) | 3.33576656 |
| 41 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.33245072 |
| 42 | positive regulation of mast cell degranulation (GO:0043306) | 3.33245072 |
| 43 | response to interferon-beta (GO:0035456) | 3.32619946 |
| 44 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.31021410 |
| 45 | pinocytosis (GO:0006907) | 3.30467499 |
| 46 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.30083899 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.29821927 |
| 48 | detection of external biotic stimulus (GO:0098581) | 3.27651356 |
| 49 | superoxide anion generation (GO:0042554) | 3.26274903 |
| 50 | negative regulation of B cell proliferation (GO:0030889) | 3.25771949 |
| 51 | myeloid dendritic cell activation (GO:0001773) | 3.25683167 |
| 52 | NIK/NF-kappaB signaling (GO:0038061) | 3.25655345 |
| 53 | B cell homeostasis (GO:0001782) | 3.25252852 |
| 54 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.24651955 |
| 55 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.23721686 |
| 56 | response to host (GO:0075136) | 3.23721686 |
| 57 | response to host defenses (GO:0052200) | 3.23721686 |
| 58 | myeloid leukocyte mediated immunity (GO:0002444) | 3.23113418 |
| 59 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.18853722 |
| 60 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.16150642 |
| 61 | negative regulation of interleukin-12 production (GO:0032695) | 3.14436824 |
| 62 | defense response to protozoan (GO:0042832) | 3.13239385 |
| 63 | B cell mediated immunity (GO:0019724) | 3.11892269 |
| 64 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.11568658 |
| 65 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.09683422 |
| 66 | positive regulation of granulocyte differentiation (GO:0030854) | 3.08691953 |
| 67 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.06376764 |
| 68 | regulation of female gonad development (GO:2000194) | 3.06290613 |
| 69 | leukocyte aggregation (GO:0070486) | 3.05940178 |
| 70 | type I interferon signaling pathway (GO:0060337) | 3.03811725 |
| 71 | cellular response to type I interferon (GO:0071357) | 3.03811725 |
| 72 | response to type I interferon (GO:0034340) | 3.03429264 |
| 73 | thrombin receptor signaling pathway (GO:0070493) | 3.03363620 |
| 74 | response to protozoan (GO:0001562) | 3.01028466 |
| 75 | regulation of antigen processing and presentation (GO:0002577) | 2.98492276 |
| 76 | regulation of B cell differentiation (GO:0045577) | 2.96605775 |
| 77 | negative regulation of T cell mediated immunity (GO:0002710) | 2.94454331 |
| 78 | regulation of mast cell activation (GO:0033003) | 2.94370978 |
| 79 | protein K11-linked deubiquitination (GO:0035871) | 2.93365839 |
| 80 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.93057110 |
| 81 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.93057110 |
| 82 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.93022681 |
| 83 | leukocyte mediated cytotoxicity (GO:0001909) | 2.92694952 |
| 84 | macrophage activation (GO:0042116) | 2.91971412 |
| 85 | response to interferon-alpha (GO:0035455) | 2.91542432 |
| 86 | regulation of mast cell degranulation (GO:0043304) | 2.87706195 |
| 87 | positive regulation of interferon-beta production (GO:0032728) | 2.87443535 |
| 88 | actin nucleation (GO:0045010) | 2.87192744 |
| 89 | regulation of leukocyte degranulation (GO:0043300) | 2.86768722 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.86455367 |
| 91 | natural killer cell mediated immunity (GO:0002228) | 2.86446768 |
| 92 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.86446768 |
| 93 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85879157 |
| 94 | detection of biotic stimulus (GO:0009595) | 2.84415421 |
| 95 | positive regulation of mast cell activation (GO:0033005) | 2.84364746 |
| 96 | negative regulation of interleukin-17 production (GO:0032700) | 2.83733937 |
| 97 | establishment of skin barrier (GO:0061436) | 2.83312093 |
| 98 | microglial cell activation (GO:0001774) | 2.82731171 |
| 99 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.82703655 |
| 100 | interferon-gamma production (GO:0032609) | 2.82591036 |
| 101 | hepatocyte apoptotic process (GO:0097284) | 2.82017539 |
| 102 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.81870501 |
| 103 | mast cell activation (GO:0045576) | 2.81281998 |
| 104 | myeloid leukocyte activation (GO:0002274) | 2.80297284 |
| 105 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.80164671 |
| 106 | germinal center formation (GO:0002467) | 2.79775465 |
| 107 | regulation of hypersensitivity (GO:0002883) | 2.78815122 |
| 108 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.77289919 |
| 109 | positive regulation of leukocyte degranulation (GO:0043302) | 2.76485533 |
| 110 | negative regulation of interleukin-8 production (GO:0032717) | 2.75855586 |
| 111 | positive thymic T cell selection (GO:0045059) | 2.74674984 |
| 112 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.74290492 |
| 113 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.73978221 |
| 114 | positive regulation of macrophage differentiation (GO:0045651) | 2.73952207 |
| 115 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.72832146 |
| 116 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.72398799 |
| 117 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.71602739 |
| 118 | detection of other organism (GO:0098543) | 2.70913521 |
| 119 | regulation of tolerance induction (GO:0002643) | 2.70791060 |
| 120 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.69993427 |
| 121 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.69564880 |
| 122 | * B cell receptor signaling pathway (GO:0050853) | 2.69235836 |
| 123 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.69090630 |
| 124 | T cell homeostasis (GO:0043029) | 2.68809103 |
| 125 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.68016642 |
| 126 | cellular response to zinc ion (GO:0071294) | 2.67329446 |
| 127 | negative regulation of growth of symbiont in host (GO:0044130) | 2.67267677 |
| 128 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.67267677 |
| 129 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.67267677 |
| 130 | regulation of growth of symbiont in host (GO:0044126) | 2.67267677 |
| 131 | activated T cell proliferation (GO:0050798) | 2.67227363 |
| 132 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.66922862 |
| 133 | regulation of germinal center formation (GO:0002634) | 2.66870796 |
| 134 | myeloid dendritic cell differentiation (GO:0043011) | 2.66428015 |
| 135 | regulation of RIG-I signaling pathway (GO:0039535) | 2.65857853 |
| 136 | cytokine secretion (GO:0050663) | 2.65760394 |
| 137 | regulation of gamma-delta T cell activation (GO:0046643) | 2.62973366 |
| 138 | T-helper cell differentiation (GO:0042093) | 2.61527064 |
| 139 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.61527064 |
| 140 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.61328899 |
| 141 | cellular response to ethanol (GO:0071361) | 2.58411534 |
| 142 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.57046620 |
| 143 | dendritic cell migration (GO:0036336) | 2.56347872 |
| 144 | regulation of water loss via skin (GO:0033561) | 2.56097105 |
| 145 | piRNA metabolic process (GO:0034587) | 2.55702313 |
| 146 | negative regulation of granulocyte differentiation (GO:0030853) | 2.55631097 |
| 147 | oocyte development (GO:0048599) | 2.53229136 |
| 148 | response to interleukin-15 (GO:0070672) | 2.52264727 |
| 149 | negative thymic T cell selection (GO:0045060) | 2.51879579 |
| 150 | regulation of granulocyte differentiation (GO:0030852) | 2.51407595 |
| 151 | positive regulation of regulated secretory pathway (GO:1903307) | 2.51002303 |
| 152 | megakaryocyte development (GO:0035855) | 2.45981578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.74290608 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.21982130 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.57564533 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.28177904 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.15995937 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.12880380 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.97655132 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.96487303 |
| 9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.83719158 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.81807463 |
| 11 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.79419050 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.65738836 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.43553621 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.23196862 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.22550317 |
| 16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.08515391 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.03293953 |
| 18 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.00603046 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.81190055 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.57489877 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.50280569 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.38314315 |
| 23 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.27620883 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.21548753 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21360909 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.17261747 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.15717190 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.14931557 |
| 29 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.12892944 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.06495895 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.01016046 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.99400971 |
| 33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.98559413 |
| 34 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.96948282 |
| 35 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.96322170 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95538531 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.86916185 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.85308636 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.84826555 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.81939092 |
| 41 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79073003 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.73818237 |
| 43 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.71622552 |
| 44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.70063671 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65864365 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.59975108 |
| 47 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.58382980 |
| 48 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57449744 |
| 49 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54935060 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.53524195 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51876705 |
| 52 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.45157404 |
| 53 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.43796918 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.41227666 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39927561 |
| 56 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.39696216 |
| 57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.38031166 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.37137293 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36065090 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35316635 |
| 61 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.34921888 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34762693 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33440688 |
| 64 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.32421076 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31009706 |
| 66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29473223 |
| 67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28207625 |
| 68 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.27402840 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27161105 |
| 70 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26965543 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26361801 |
| 72 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26006593 |
| 73 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.25587375 |
| 74 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.23053483 |
| 75 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.21296993 |
| 76 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20953806 |
| 77 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.20371588 |
| 78 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.19339565 |
| 79 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.19307337 |
| 80 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17021077 |
| 81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15809997 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15266680 |
| 83 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.15135519 |
| 84 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.15001079 |
| 85 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.12675810 |
| 86 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09812905 |
| 87 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09282899 |
| 88 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08963711 |
| 89 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07588332 |
| 90 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.07496982 |
| 91 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06166109 |
| 92 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.05192310 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04224347 |
| 94 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03989209 |
| 95 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02849422 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02388395 |
| 97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00818664 |
| 98 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99251977 |
| 99 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.98943726 |
| 100 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98601894 |
| 101 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97430465 |
| 102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95863678 |
| 103 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94878548 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94636088 |
| 105 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.94463249 |
| 106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93968400 |
| 107 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93391039 |
| 108 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.92680452 |
| 109 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.91350766 |
| 110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90396760 |
| 111 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.89116183 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89076784 |
| 113 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88758412 |
| 114 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.88758412 |
| 115 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.88751620 |
| 116 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88367800 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88341391 |
| 118 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86428353 |
| 119 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.86247853 |
| 120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84323043 |
| 121 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.83355061 |
| 122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82852149 |
| 123 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.82097827 |
| 124 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.82020012 |
| 125 | MAF_26560356_Chip-Seq_TH2_Human | 0.81998494 |
| 126 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81358214 |
| 127 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.81274248 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81105198 |
| 129 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.81019716 |
| 130 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80899011 |
| 131 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.80743633 |
| 132 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79721047 |
| 133 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.78128538 |
| 134 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75686893 |
| 135 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.74614595 |
| 136 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74216374 |
| 137 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.72623313 |
| 138 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.71933106 |
| 139 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.71376233 |
| 140 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.71167153 |
| 141 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.68613972 |
| 142 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67974595 |
| 143 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.66599970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.47576432 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.29585246 |
| 3 | MP0003436_decreased_susceptibility_to | 3.27158525 |
| 4 | MP0009785_altered_susceptibility_to | 3.02060082 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.96771816 |
| 6 | MP0002419_abnormal_innate_immunity | 2.90930753 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 2.83506382 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.78845281 |
| 9 | MP0000685_abnormal_immune_system | 2.71904107 |
| 10 | MP0003303_peritoneal_inflammation | 2.68201665 |
| 11 | MP0005025_abnormal_response_to | 2.66717004 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.50837885 |
| 13 | MP0009278_abnormal_bone_marrow | 2.48693482 |
| 14 | MP0005671_abnormal_response_to | 2.47366091 |
| 15 | MP0005174_abnormal_tail_pigmentation | 2.46331994 |
| 16 | MP0001790_abnormal_immune_system | 2.44416720 |
| 17 | MP0005387_immune_system_phenotype | 2.44416720 |
| 18 | MP0002396_abnormal_hematopoietic_system | 2.42794503 |
| 19 | MP0001800_abnormal_humoral_immune | 2.42370681 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.30540571 |
| 21 | MP0002723_abnormal_immune_serum | 2.29073030 |
| 22 | MP0001819_abnormal_immune_cell | 2.28305252 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.27607548 |
| 24 | MP0001545_abnormal_hematopoietic_system | 2.26467193 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 2.26467193 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.24265662 |
| 27 | MP0002006_tumorigenesis | 2.16545555 |
| 28 | MP0003724_increased_susceptibility_to | 2.16084333 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 2.12905199 |
| 30 | MP0004808_abnormal_hematopoietic_stem | 2.11937605 |
| 31 | MP0004264_abnormal_extraembryonic_tissu | 2.09104377 |
| 32 | MP0005058_abnormal_lysosome_morphology | 2.04840010 |
| 33 | MP0004043_abnormal_pH_regulation | 2.03650936 |
| 34 | MP0004381_abnormal_hair_follicle | 1.95154510 |
| 35 | MP0002398_abnormal_bone_marrow | 1.90170564 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.89394006 |
| 37 | MP0001853_heart_inflammation | 1.88436033 |
| 38 | MP0002405_respiratory_system_inflammati | 1.86159292 |
| 39 | MP0002796_impaired_skin_barrier | 1.84896417 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.83735951 |
| 41 | MP0004510_myositis | 1.81709462 |
| 42 | MP0000716_abnormal_immune_system | 1.77107821 |
| 43 | MP0004947_skin_inflammation | 1.73025012 |
| 44 | MP0005075_abnormal_melanosome_morpholog | 1.72868595 |
| 45 | MP0010678_abnormal_skin_adnexa | 1.72507964 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.71548005 |
| 47 | MP0003763_abnormal_thymus_physiology | 1.70781115 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.69110758 |
| 49 | MP0003195_calcinosis | 1.68272872 |
| 50 | MP0006082_CNS_inflammation | 1.66096934 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.63958357 |
| 52 | MP0003448_altered_tumor_morphology | 1.63642023 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.56009779 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.55570883 |
| 55 | MP0002429_abnormal_blood_cell | 1.47898930 |
| 56 | MP0002722_abnormal_immune_system | 1.46232155 |
| 57 | MP0000490_abnormal_crypts_of | 1.43789429 |
| 58 | MP0000858_altered_metastatic_potential | 1.39649565 |
| 59 | MP0000343_altered_response_to | 1.38812279 |
| 60 | MP0000427_abnormal_hair_cycle | 1.36456918 |
| 61 | MP0010307_abnormal_tumor_latency | 1.34274208 |
| 62 | MP0001873_stomach_inflammation | 1.34217329 |
| 63 | MP0009764_decreased_sensitivity_to | 1.32652815 |
| 64 | MP0001765_abnormal_ion_homeostasis | 1.28957121 |
| 65 | MP0000015_abnormal_ear_pigmentation | 1.26194113 |
| 66 | MP0003075_altered_response_to | 1.25757204 |
| 67 | MP0002132_abnormal_respiratory_system | 1.22997720 |
| 68 | MP0003252_abnormal_bile_duct | 1.22872975 |
| 69 | MP0005310_abnormal_salivary_gland | 1.20029168 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 1.20024817 |
| 71 | MP0002095_abnormal_skin_pigmentation | 1.18082316 |
| 72 | MP0003566_abnormal_cell_adhesion | 1.17749527 |
| 73 | MP0002139_abnormal_hepatobiliary_system | 1.16687412 |
| 74 | MP0001851_eye_inflammation | 1.14505554 |
| 75 | MP0003828_pulmonary_edema | 1.12847501 |
| 76 | * MP0008469_abnormal_protein_level | 1.12682506 |
| 77 | MP0000703_abnormal_thymus_morphology | 1.12184412 |
| 78 | MP0002098_abnormal_vibrissa_morphology | 1.11408786 |
| 79 | MP0008007_abnormal_cellular_replicative | 1.11121499 |
| 80 | MP0005076_abnormal_cell_differentiation | 1.09810365 |
| 81 | MP0002998_abnormal_bone_remodeling | 1.04420835 |
| 82 | MP0009379_abnormal_foot_pigmentation | 1.04313101 |
| 83 | MP0005083_abnormal_biliary_tract | 1.01704794 |
| 84 | MP0005409_darkened_coat_color | 0.99125823 |
| 85 | MP0008877_abnormal_DNA_methylation | 0.96001575 |
| 86 | MP0002933_joint_inflammation | 0.95259536 |
| 87 | MP0005647_abnormal_sex_gland | 0.90594512 |
| 88 | MP0000371_diluted_coat_color | 0.90586630 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 0.90128951 |
| 90 | MP0003866_abnormal_defecation | 0.89670760 |
| 91 | MP0003045_fibrosis | 0.89661946 |
| 92 | MP0006054_spinal_hemorrhage | 0.88617876 |
| 93 | MP0003638_abnormal_response/metabolism_ | 0.88261465 |
| 94 | MP0001663_abnormal_digestive_system | 0.86426338 |
| 95 | MP0002254_reproductive_system_inflammat | 0.86285533 |
| 96 | MP0000383_abnormal_hair_follicle | 0.84362079 |
| 97 | MP0001919_abnormal_reproductive_system | 0.83989846 |
| 98 | MP0005390_skeleton_phenotype | 0.82332204 |
| 99 | MP0004883_abnormal_blood_vessel | 0.81231940 |
| 100 | MP0008260_abnormal_autophagy | 0.79722316 |
| 101 | MP0005166_decreased_susceptibility_to | 0.78704596 |
| 102 | MP0005501_abnormal_skin_physiology | 0.78449432 |
| 103 | MP0010352_gastrointestinal_tract_polyps | 0.78271536 |
| 104 | MP0005085_abnormal_gallbladder_physiolo | 0.77970185 |
| 105 | * MP0003183_abnormal_peptide_metabolism | 0.77683546 |
| 106 | MP0008875_abnormal_xenobiotic_pharmacok | 0.77556034 |
| 107 | MP0005360_urolithiasis | 0.77434624 |
| 108 | MP0000377_abnormal_hair_follicle | 0.76667644 |
| 109 | MP0002019_abnormal_tumor_incidence | 0.75494164 |
| 110 | MP0004019_abnormal_vitamin_homeostasis | 0.72901368 |
| 111 | MP0009643_abnormal_urine_homeostasis | 0.72844643 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.72554988 |
| 113 | MP0002277_abnormal_respiratory_mucosa | 0.72057332 |
| 114 | MP0002163_abnormal_gland_morphology | 0.71974391 |
| 115 | MP0003091_abnormal_cell_migration | 0.71908989 |
| 116 | MP0002009_preneoplasia | 0.71185221 |
| 117 | MP0003795_abnormal_bone_structure | 0.70663324 |
| 118 | MP0005164_abnormal_response_to | 0.69900707 |
| 119 | MP0009763_increased_sensitivity_to | 0.66206316 |
| 120 | MP0003943_abnormal_hepatobiliary_system | 0.65921158 |
| 121 | MP0000249_abnormal_blood_vessel | 0.61424196 |
| 122 | MP0001958_emphysema | 0.59832726 |
| 123 | MP0005167_abnormal_blood-brain_barrier | 0.59450311 |
| 124 | MP0001191_abnormal_skin_condition | 0.59031224 |
| 125 | MP0010094_abnormal_chromosome_stability | 0.55664602 |
| 126 | MP0001986_abnormal_taste_sensitivity | 0.54824153 |
| 127 | MP0003191_abnormal_cellular_cholesterol | 0.54804955 |
| 128 | MP0001216_abnormal_epidermal_layer | 0.54558827 |
| 129 | MP0002075_abnormal_coat/hair_pigmentati | 0.53134482 |
| 130 | MP0001346_abnormal_lacrimal_gland | 0.53016138 |
| 131 | MP0003077_abnormal_cell_cycle | 0.52972573 |
| 132 | MP0002060_abnormal_skin_morphology | 0.52292651 |
| 133 | MP0008057_abnormal_DNA_replication | 0.52155151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.29278692 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.71270472 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.52937450 |
| 4 | Myositis (HP:0100614) | 5.00937623 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.62628855 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 4.29575938 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.27420804 |
| 8 | Orchitis (HP:0100796) | 4.11296960 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 3.99718362 |
| 10 | Optic neuritis (HP:0100653) | 3.99718362 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.90046274 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.89140672 |
| 13 | Recurrent skin infections (HP:0001581) | 3.81127708 |
| 14 | Thrombocytosis (HP:0001894) | 3.78796768 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.78639965 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 3.72235328 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.71593712 |
| 18 | Chronic otitis media (HP:0000389) | 3.59855940 |
| 19 | Recurrent viral infections (HP:0004429) | 3.54900808 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.49662719 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.49662719 |
| 22 | Obstructive lung disease (HP:0006536) | 3.47931862 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.47931862 |
| 24 | Vasculitis (HP:0002633) | 3.33358270 |
| 25 | Periodontitis (HP:0000704) | 3.29504388 |
| 26 | Gingivitis (HP:0000230) | 3.28906554 |
| 27 | Cellulitis (HP:0100658) | 3.13394304 |
| 28 | Abnormality of chloride homeostasis (HP:0011422) | 3.09771426 |
| 29 | Stomatitis (HP:0010280) | 3.07800122 |
| 30 | Decreased circulating renin level (HP:0003351) | 2.99765301 |
| 31 | Meningitis (HP:0001287) | 2.99424261 |
| 32 | Prostate neoplasm (HP:0100787) | 2.97649894 |
| 33 | Abnormality of T cell physiology (HP:0011840) | 2.97272480 |
| 34 | Arterial thrombosis (HP:0004420) | 2.97197676 |
| 35 | Metabolic alkalosis (HP:0200114) | 2.96956864 |
| 36 | Keratoconjunctivitis sicca (HP:0001097) | 2.90816228 |
| 37 | Abnormality of B cell number (HP:0010975) | 2.88307495 |
| 38 | Vacuolated lymphocytes (HP:0001922) | 2.87420249 |
| 39 | Abnormality of renin-angiotensin system (HP:0000847) | 2.87368316 |
| 40 | Disinhibition (HP:0000734) | 2.83938273 |
| 41 | Abnormality of the prostate (HP:0008775) | 2.79969029 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.78450356 |
| 43 | Keratoconjunctivitis (HP:0001096) | 2.66635735 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.64162639 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.63304441 |
| 46 | Albinism (HP:0001022) | 2.62470052 |
| 47 | Thick nail (HP:0001805) | 2.60869261 |
| 48 | Osteomyelitis (HP:0002754) | 2.59475208 |
| 49 | Absent/shortened dynein arms (HP:0200106) | 2.59179054 |
| 50 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.59179054 |
| 51 | Abnormality of T cell number (HP:0011839) | 2.55483820 |
| 52 | Hematochezia (HP:0002573) | 2.54727499 |
| 53 | Hypokalemic alkalosis (HP:0001949) | 2.53446680 |
| 54 | Hyperaldosteronism (HP:0000859) | 2.53259358 |
| 55 | IgM deficiency (HP:0002850) | 2.52286894 |
| 56 | Stomach cancer (HP:0012126) | 2.49821779 |
| 57 | Gastrointestinal infarctions (HP:0005244) | 2.47718706 |
| 58 | Eosinophilia (HP:0001880) | 2.47286476 |
| 59 | Absent frontal sinuses (HP:0002688) | 2.44262867 |
| 60 | B lymphocytopenia (HP:0010976) | 2.42753734 |
| 61 | Lip pit (HP:0100267) | 2.41549825 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.37649869 |
| 63 | Leukocytosis (HP:0001974) | 2.37199563 |
| 64 | Interstitial pulmonary disease (HP:0006530) | 2.36550550 |
| 65 | Pustule (HP:0200039) | 2.32558801 |
| 66 | Abnormality of T cells (HP:0002843) | 2.31722331 |
| 67 | Recurrent pneumonia (HP:0006532) | 2.31148536 |
| 68 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.30110047 |
| 69 | Increased circulating renin level (HP:0000848) | 2.29553024 |
| 70 | Petechiae (HP:0000967) | 2.29423737 |
| 71 | Hypergammaglobulinemia (HP:0010702) | 2.29366892 |
| 72 | Recurrent bronchitis (HP:0002837) | 2.29131455 |
| 73 | Urticaria (HP:0001025) | 2.27951889 |
| 74 | Chronic sinusitis (HP:0011109) | 2.27798182 |
| 75 | Chest pain (HP:0100749) | 2.27624528 |
| 76 | Hemoptysis (HP:0002105) | 2.24617713 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.23719162 |
| 78 | Bronchitis (HP:0012387) | 2.23462536 |
| 79 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.23197149 |
| 80 | Basal ganglia calcification (HP:0002135) | 2.20626031 |
| 81 | Thyroiditis (HP:0100646) | 2.20441927 |
| 82 | Alveolar cell carcinoma (HP:0006519) | 2.18074052 |
| 83 | T lymphocytopenia (HP:0005403) | 2.17664144 |
| 84 | Prolonged bleeding time (HP:0003010) | 2.17582645 |
| 85 | Increased IgE level (HP:0003212) | 2.17290144 |
| 86 | Colitis (HP:0002583) | 2.14611935 |
| 87 | Abnormality of the axillary hair (HP:0100134) | 2.12640862 |
| 88 | Abnormality of secondary sexual hair (HP:0009888) | 2.12640862 |
| 89 | Chronic diarrhea (HP:0002028) | 2.12602334 |
| 90 | Pulmonary embolism (HP:0002204) | 2.12040779 |
| 91 | Abnormality of the lumbar spine (HP:0100712) | 2.11942578 |
| 92 | Acute lymphatic leukemia (HP:0006721) | 2.11568605 |
| 93 | Abnormality of the pleura (HP:0002103) | 2.10539942 |
| 94 | Gastrointestinal inflammation (HP:0004386) | 2.09775607 |
| 95 | Acute myeloid leukemia (HP:0004808) | 2.07572346 |
| 96 | Granulocytopenia (HP:0001913) | 2.06385837 |
| 97 | Alkalosis (HP:0001948) | 2.05747360 |
| 98 | Skin ulcer (HP:0200042) | 2.05668743 |
| 99 | Recurrent lower respiratory tract infections (HP:0002783) | 2.04488044 |
| 100 | Encephalitis (HP:0002383) | 2.03978230 |
| 101 | Curly hair (HP:0002212) | 2.02693520 |
| 102 | Sepsis (HP:0100806) | 2.01254576 |
| 103 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.00123453 |
| 104 | Abnormal ciliary motility (HP:0012262) | 1.99384469 |
| 105 | Papilledema (HP:0001085) | 1.98770191 |
| 106 | Abnormality of glycolipid metabolism (HP:0010969) | 1.98438051 |
| 107 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.98438051 |
| 108 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.98438051 |
| 109 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.98321227 |
| 110 | Osteolytic defects of the hand bones (HP:0009699) | 1.98321227 |
| 111 | Increased IgM level (HP:0003496) | 1.98114166 |
| 112 | Panhypogammaglobulinemia (HP:0003139) | 1.97888481 |
| 113 | Inappropriate behavior (HP:0000719) | 1.96224880 |
| 114 | IgG deficiency (HP:0004315) | 1.96049269 |
| 115 | Abnormality of eosinophils (HP:0001879) | 1.95295677 |
| 116 | Chronic bronchitis (HP:0004469) | 1.95206797 |
| 117 | Loss of speech (HP:0002371) | 1.95093223 |
| 118 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.94865818 |
| 119 | Cone-rod dystrophy (HP:0000548) | 1.94145990 |
| 120 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.93891515 |
| 121 | Premature loss of primary teeth (HP:0006323) | 1.93114755 |
| 122 | Gingival bleeding (HP:0000225) | 1.92459044 |
| 123 | Abnormality of the thoracic spine (HP:0100711) | 1.92278448 |
| 124 | Bronchiectasis (HP:0002110) | 1.89417264 |
| 125 | Agammaglobulinemia (HP:0004432) | 1.88787219 |
| 126 | Dysostosis multiplex (HP:0000943) | 1.88559684 |
| 127 | Autoimmune hemolytic anemia (HP:0001890) | 1.88215605 |
| 128 | Gangrene (HP:0100758) | 1.87969901 |
| 129 | Hyperkalemia (HP:0002153) | 1.87245123 |
| 130 | Systemic lupus erythematosus (HP:0002725) | 1.87048263 |
| 131 | Lymphopenia (HP:0001888) | 1.86640088 |
| 132 | Abnormality of the fingertips (HP:0001211) | 1.86220808 |
| 133 | Thoracic kyphosis (HP:0002942) | 1.85709601 |
| 134 | Recurrent sinusitis (HP:0011108) | 1.85372221 |
| 135 | Papillary thyroid carcinoma (HP:0002895) | 1.84600790 |
| 136 | Tetany (HP:0001281) | 1.84196173 |
| 137 | Syringomyelia (HP:0003396) | 1.83299205 |
| 138 | Spinal cord lesions (HP:0100561) | 1.83299205 |
| 139 | Epistaxis (HP:0000421) | 1.81906043 |
| 140 | Deformed sella turcica (HP:0002681) | 1.80378459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.70255491 |
| 2 | KIT | 3.31483410 |
| 3 | MAP4K1 | 2.93124271 |
| 4 | IRAK4 | 2.83459047 |
| 5 | TBK1 | 2.71027750 |
| 6 | TYK2 | 2.45204362 |
| 7 | JAK3 | 2.42831747 |
| 8 | TEC | 2.42213264 |
| 9 | RIPK4 | 2.36998895 |
| 10 | IKBKE | 2.24368212 |
| 11 | FES | 2.20592415 |
| 12 | BTK | 2.19841037 |
| 13 | OXSR1 | 2.13268309 |
| 14 | TXK | 1.99368033 |
| 15 | IKBKB | 1.92978800 |
| 16 | CSF1R | 1.89590392 |
| 17 | SIK3 | 1.86560768 |
| 18 | BLK | 1.75911693 |
| 19 | SYK | 1.68233590 |
| 20 | HCK | 1.66829691 |
| 21 | TGFBR2 | 1.63230004 |
| 22 | CHUK | 1.62543883 |
| 23 | IRAK3 | 1.55235513 |
| 24 | MAP3K2 | 1.54218587 |
| 25 | FGFR3 | 1.54136496 |
| 26 | PIM2 | 1.49457135 |
| 27 | INSRR | 1.48392296 |
| 28 | IRAK1 | 1.47271432 |
| 29 | JAK1 | 1.44770255 |
| 30 | CLK1 | 1.42038853 |
| 31 | MAP2K3 | 1.41423547 |
| 32 | EPHB1 | 1.40423864 |
| 33 | STK10 | 1.38604385 |
| 34 | PIK3CG | 1.37914368 |
| 35 | TRPM7 | 1.35329661 |
| 36 | ERBB3 | 1.32874422 |
| 37 | TAOK3 | 1.30065782 |
| 38 | ZAP70 | 1.28783603 |
| 39 | LYN | 1.25565711 |
| 40 | MAP3K1 | 1.24913248 |
| 41 | FER | 1.24570819 |
| 42 | LCK | 1.22933554 |
| 43 | WNK3 | 1.19693468 |
| 44 | NME2 | 1.19333163 |
| 45 | ITK | 1.19188614 |
| 46 | CSK | 1.18508969 |
| 47 | MAPKAPK3 | 1.17249290 |
| 48 | MATK | 1.16860891 |
| 49 | MKNK1 | 1.16176024 |
| 50 | NUAK1 | 1.12576645 |
| 51 | RPS6KB2 | 1.11504755 |
| 52 | RPS6KA4 | 1.11440852 |
| 53 | CDK6 | 1.10193784 |
| 54 | PIM1 | 1.09082366 |
| 55 | STK39 | 1.08185837 |
| 56 | FLT3 | 1.05268166 |
| 57 | CDK12 | 1.04662533 |
| 58 | EIF2AK1 | 1.04000368 |
| 59 | ERN1 | 1.00442674 |
| 60 | NEK6 | 1.00006331 |
| 61 | SIK2 | 0.99955420 |
| 62 | LATS1 | 0.98947373 |
| 63 | EEF2K | 0.95069949 |
| 64 | EIF2AK2 | 0.90596669 |
| 65 | LRRK2 | 0.90455034 |
| 66 | SCYL2 | 0.89301251 |
| 67 | MAP3K12 | 0.87925680 |
| 68 | STK4 | 0.85794961 |
| 69 | RIPK1 | 0.85781373 |
| 70 | YES1 | 0.84600390 |
| 71 | JAK2 | 0.84550893 |
| 72 | PIK3CA | 0.83258126 |
| 73 | TTN | 0.81584511 |
| 74 | BRSK2 | 0.80737500 |
| 75 | MST4 | 0.79771832 |
| 76 | FGFR4 | 0.78595407 |
| 77 | MARK3 | 0.78058277 |
| 78 | SGK2 | 0.77627333 |
| 79 | PDK1 | 0.77288960 |
| 80 | BMPR2 | 0.77079062 |
| 81 | MAP3K13 | 0.74742081 |
| 82 | EIF2AK3 | 0.74630260 |
| 83 | TIE1 | 0.73561858 |
| 84 | PRKCQ | 0.71015933 |
| 85 | TGFBR1 | 0.67571859 |
| 86 | ABL1 | 0.65439413 |
| 87 | PTK6 | 0.64369934 |
| 88 | NEK9 | 0.64141393 |
| 89 | PAK4 | 0.63905060 |
| 90 | STK3 | 0.62571551 |
| 91 | TAOK1 | 0.60914493 |
| 92 | PRPF4B | 0.60778984 |
| 93 | PRKCD | 0.60436064 |
| 94 | HIPK2 | 0.60011449 |
| 95 | GRK6 | 0.59216791 |
| 96 | CAMKK2 | 0.58323993 |
| 97 | TNIK | 0.58108602 |
| 98 | WNK1 | 0.57627857 |
| 99 | MAP3K6 | 0.56786350 |
| 100 | MAPKAPK5 | 0.56607180 |
| 101 | ADRBK2 | 0.56453102 |
| 102 | RPS6KA6 | 0.56060985 |
| 103 | CAMK1D | 0.55876304 |
| 104 | SGK3 | 0.53756463 |
| 105 | FGR | 0.53701188 |
| 106 | EGFR | 0.53422929 |
| 107 | NLK | 0.52731838 |
| 108 | ATR | 0.52401468 |
| 109 | GRK7 | 0.51768592 |
| 110 | STK24 | 0.51310862 |
| 111 | PRKAA2 | 0.50603651 |
| 112 | MARK2 | 0.49099204 |
| 113 | MAP2K2 | 0.48436562 |
| 114 | TNK2 | 0.48411775 |
| 115 | MOS | 0.48279375 |
| 116 | MAP3K5 | 0.47465161 |
| 117 | PKN2 | 0.47152747 |
| 118 | MAPK11 | 0.47073487 |
| 119 | PRKG2 | 0.45143028 |
| 120 | PDPK1 | 0.45113985 |
| 121 | MAPK4 | 0.44909791 |
| 122 | ACVR1B | 0.44259854 |
| 123 | MAPKAPK2 | 0.43911392 |
| 124 | ERBB2 | 0.43387288 |
| 125 | RPS6KC1 | 0.41950126 |
| 126 | RPS6KL1 | 0.41950126 |
| 127 | DYRK1B | 0.41470977 |
| 128 | MAP3K7 | 0.41157934 |
| 129 | RPS6KB1 | 0.40685015 |
| 130 | MAP3K3 | 0.40498483 |
| 131 | MKNK2 | 0.39697227 |
| 132 | CDK4 | 0.38571571 |
| 133 | EPHA3 | 0.38411935 |
| 134 | MAP2K6 | 0.37586649 |
| 135 | IGF1R | 0.37547329 |
| 136 | FRK | 0.37431815 |
| 137 | BRD4 | 0.35116020 |
| 138 | IRAK2 | 0.35104787 |
| 139 | MAPK7 | 0.33377907 |
| 140 | MAPK3 | 0.29884915 |
| 141 | FYN | 0.29332292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.07358021 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38602212 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.31626803 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.28068664 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.15762245 |
| 6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.15666742 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02850252 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.02214941 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.96835903 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 1.95478666 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.94289746 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.93557191 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.84526160 |
| 14 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.82406285 |
| 15 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.80839160 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.78818688 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74920895 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.69743220 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.69316678 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.67524526 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.67284700 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.64693280 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.63140375 |
| 24 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.61968176 |
| 25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.61842016 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.58655806 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.53952446 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.48231830 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48166947 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.47263459 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.45342501 |
| 32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.44553268 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.43043775 |
| 34 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.41329232 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.39425400 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36061481 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.35752348 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.34103559 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.28815402 |
| 40 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28400227 |
| 41 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26129616 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.25287265 |
| 43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.25273430 |
| 44 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24930784 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24617526 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.21492397 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.18600566 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18136956 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17325383 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 1.17257381 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.16471268 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16442494 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 1.12008175 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11299077 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08935025 |
| 56 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07883883 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99364324 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96328402 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95647626 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.94207035 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.93131499 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91170356 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.89550571 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89502107 |
| 65 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89299441 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.88489332 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.87636335 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.87117962 |
| 69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.86630060 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85588870 |
| 71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85049889 |
| 72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85036599 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.84254469 |
| 74 | DNA replication_Homo sapiens_hsa03030 | 0.83914582 |
| 75 | Base excision repair_Homo sapiens_hsa03410 | 0.82812608 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81982140 |
| 77 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.81727981 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.76716675 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74726015 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.74554893 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74438181 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72299718 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71368729 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68330799 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66658845 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65625537 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63540587 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63454144 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63042130 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63032676 |
| 91 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61823962 |
| 92 | Homologous recombination_Homo sapiens_hsa03440 | 0.61749125 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59962218 |
| 94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55647611 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55456617 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54154281 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.53334234 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50837794 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50662120 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50454223 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50206119 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.49274689 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47760064 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46959324 |
| 105 | Cell cycle_Homo sapiens_hsa04110 | 0.46883348 |
| 106 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46658767 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45216893 |
| 108 | Long-term depression_Homo sapiens_hsa04730 | 0.44619410 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.43841137 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43702451 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43181374 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.43142037 |
| 113 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43064538 |
| 114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42131427 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40125181 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40076805 |
| 117 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39492836 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39065961 |
| 119 | Ribosome_Homo sapiens_hsa03010 | 0.38989495 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38517515 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.38014967 |
| 122 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37877194 |
| 123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35178568 |
| 124 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34757336 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34476671 |
| 126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34005909 |
| 127 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32843418 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31956262 |
| 129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31682452 |
| 130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29666514 |
| 131 | * Focal adhesion_Homo sapiens_hsa04510 | 0.29254088 |

